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RSPO4 Is the Major Gene in Autosomal-Recessive
Anonychia and Mutations Cluster in the Furin-Like
Cysteine-Rich Domains of the Wnt Signaling Ligand
R-spondin 4
Nadina Ortiz Bru¨chle1, Jorge Frank2,3, Valeska Frank1, Jan Senderek1, Ahmet Akar4, Erol Koc4, Dimitris
Rigopoulos5, Maurice van Steensel2,3, Klaus Zerres1 and Carsten Bergmann1
Congenital anonychia is a rare autosomal-recessive disorder characterized by the absence of finger- and
toenails. Recently, we and others identified the secreted Wnt signaling ligand R-spondin 4 (RSPO4) as the first
gene known to be responsible for inherited anonychia. R-spondins are secreted proteins that activate the Wnt/
b-catenin signaling pathway. This puts anonychia on the growing list of congenital malformation syndromes
caused by Wnt signaling pathway defects. Here, we expand the RSPO4 mutational spectrum by identification of
the previously unknown mutations c.190C4T (p.Arg64Cys) in exon 2 and c.301C4T (p.Gln101X) in exon 3,
thereby corroborating R-spondin 4 as the major protein in autosomal-recessive anonychia. Almost all RSPO4
mutations detected so far affect the highly conserved exons 2 and 3. Thus, we postulate that RSPO4 mutations
preferentially cluster in the furin-like cysteine-rich domains of R-spondin 4, which is in line with experimental
data proposing that for b-catenin stabilization, a shortened protein comprising just these two regions is
sufficient.
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INTRODUCTION
Congenital anonychia (OMIM 206800) is defined as the
absence of finger- and toenails (Baran et al., 2001). Usually,
anonychia and its milder phenotypic variant hyponychia
occur as a feature of genetic syndromes and may be
associated with significant skeletal and limb anomalies.
Well-known examples are Coffin–Siris syndrome (OMIM
135900), several ectodermal dysplasias (OMIM 129490,
300291, and 224900), nail–patella syndrome (OMIM
161200), and brachydactyly type B (OMIM 113000). Most
of these disorders are transmitted in an autosomal-dominant
mode. In contrast, isolated, non-syndromic anonychia with-
out additional features is a rare entity that usually follows
autosomal-recessive inheritance with variable expression
even within a given family. The encountered nail phenotypes
range from no nail field to a nail field of reduced size with an
absent or rudimentary nail (Littman and Levin, 1964).
Recently, we and others identified homozygous and
compound heterozygous mutations in the secreted Wnt
signaling component R-spondin 4 (RSPO4) (OMIM 610573)
as the cause of autosomal-recessive anonychia congenita
(Bergmann et al., 2006; Blaydon et al., 2006). RSPO4 spans
approximately 44 kb of genomic DNA and comprises five
exons that encode a secreted protein of 234 amino acids (Kim
et al., 2006). The R-spondin protein family was only recently
described and comprises four independent gene products in
mammals, which are widely expressed and predicted to share
a common organization with substantial structural homo-
logies (Kazanskaya et al., 2004; Blaydon et al., 2007).
Noteworthy, each of the five exons constitutes a predicted
structural domain. Whereas the N-terminal signal peptide
sequences encoded by exon 1 only share a relatively low
degree of conservation, the two adjacent cysteine-rich furin-
like domains encoded by exons 2 and 3 and the single
thrombospondin motif that is encoded by exon 4 display
significant similarity among protein family members. Finally,
the C-terminal basic region encoded by exon 5 is of varying
length and scores as a nuclear localization signal.
R-spondins have been shown to activate the Wnt/b-
catenin signaling pathway, which is evolutionarily conserved
and pivotal for embryonic development by the regulation of
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cell morphology, proliferation, and motility (Logan and
Nusse, 2004; Mulholland et al., 2005; Kim et al., 2006;
Nam et al., 2006). In accordance, inappropriate activation of
Wnt/b-catenin signaling has been demonstrated in several
human cancers (Katoh, 2005). As recently shown, all four
human R-spondin family members as well as a splice variant
of RSPO4 can induce proliferation of intestinal epithelium
(Kim et al., 2006). However, current knowledge about the
precise role of R-spondin 4 in Wnt signaling is limited. From
recent data on its related protein family member Rspo3, it can
be hypothesized that the functions of R-spondins essentially
overlap with those of the canonical Wnt ligands by binding to
the Frizzled family receptors and the low-density lipoprotein-
related receptor (LRP) receptors 5 or 6, ultimately leading to
gene activation by b-catenin and the T-cell factor (TCF)-
lymphoid enhancer factor (LEF) transcription factor complex
(Nam et al., 2006).
In this study, we sought to confirm the major role of
R-spondin 4 in autosomal-recessive anonychia by further
delineating the RSPO4 mutational spectrum in individuals
afflicted with congenital non-syndromic anonychia.
RESULTS AND DISCUSSION
In this study, we analyzed two unrelated families of Turkish
and Kazakh origin, respectively (Figures 1 and 2). Haplotype
analysis was compatible with linkage to RSPO4 on chromo-
some 20p13 in both of these families. Owing to parental
consanguinity in the Turkish pedigree, homozygous haplo-
types could a priori be expected for the disease-causing locus
in this family. In contrast, parental consanguinity was
considered unlikely in the Kazakh family. This assumption
was in line with the result of heterozygous haplotypes
obtained for the closely flanking marker D20S117 in
both affected individuals (Figure 1). Thus, identification of
the novel homozygous nonsense mutation c.301C4T
(p.Gln101X) in exon 3 of the RSPO4 gene in these individuals
was rather surprising. If one assumes that the parents are
indeed non-consanguineous, it is tempting to speculate that
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Figure 1. Pedigree and RSPO4 linkage data of the Kazakh family studied. The recombination rates of the informative flanking markers (distally, D20S117
paternally and D20S1156 maternally and D20S199 proximally for both parental haplotypes) in this family are approximately 3 cM for the paternal and
approximately 5.5 cM for the maternal haplotypes. The father of this family was not available for analysis. Therefore, paternal haplotypes in this kindred were
deduced from the haplotypes of his children. Bottom left: the right hand of the affected 2-year-old son (left) and the right hand of the affected 15-year-old
daughter of this family. The skin in the region of the absent nails was normal, and the nail bed, nail matrix, and fold were present in all fingers and toes (data not
shown). Bottom right: electropherogram depicting the novel homozygous nonsense mutation c.301C4T (p.Gln101X) in exon 3 of the RSPO4 gene.
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the paternal and maternal mutation in this kindred arose
independently. However, it might be more likely that
the parents are distantly related (possibly without knowing
it) and that a paternal marker mutation for D20S117 with
expansion from 196 base pairs (bp) to 198bp occurred
(Buschiazzo and Gemmell, 2006). The latter hypothesis is
further corroborated by the finding of homozygous haplotypes
in both patients for all other typed RSPO4 microsatellite
markers and homozygosity for the known non-coding
single-nucleotide polymorphism c.1-304C4G (rs6077512,
http://genome.ucsc.edu) in the proximal 50 untranslated region
of the RSPO4 gene.
Direct sequencing of the coding region and adjacent 50
untranslated region of the RSPO4 gene in the propositus of
the Turkish family also revealed the aforementioned known
homozygous SNP c.1-304C4G. Furthermore, we could
identify the novel, non-conservative homozygous missense
mutation c.190C4T that leads to an amino-acid exchange
from arginine to cysteine at position 64 (p.Arg64Cys) in exon
2 of the RSPO4 gene and was shown to segregate with the
phenotype in this family (Figure 2). The affected R-spondin 4
arginine residue was found to be strongly conserved in
several species throughout evolution (Figure 3). Moreover,
this mutation was not detected in 200 ethnically matched
Turkish control chromosomes tested by restriction
enzyme analysis, thereby further corroborating its pathogenic
character.
RSPO4 mutations identified so far comprise the entire
spectrum of small mutations with deletions and insertions
leading to a frameshift, nonsense, splice, and missense
mutations. Intriguingly, no genotype–phenotype correlation
can be drawn for the type or position of the causative
mutation. Of note, the majority of RSPO4 mutations detected
so far affect the highly conserved furin-like cysteine-rich
domains encoded by exons 2 and 3 (Figure 3; Bergmann
et al., 2006; Blaydon et al., 2006). This is in accordance with
experimental data suggesting that for b-catenin stabilization,
a shortened variant of R-spondin 4 comprising just these two
furin-like regions is sufficient (Kazanskaya et al., 2004; Kim
et al., 2006). RSPO4 mutation analysis in further families will
answer the intriguing question if mutations in other domains
than the highly conserved furin-like regions result in a similar
clinical phenotype or may allow for a residual protein
function conceivably giving rise to a milder expression
pattern with, for example, hyponychia or selective absence
of single nails. However, currently it is rather speculative to
predict the specific effects of the detected RSPO4 mutations
on the stability of mRNA and the mutant protein. Notwith-
standing, two different types of mutations can generally be
differentiated: (i) those resulting in amino-acid substitutions
due to missense mutations, and (ii) those leading to
premature termination codons. Non-conservative amino-acid
substitutions that affect evolutionarily highly conserved
functional domains (such as the furin-like cysteine-rich
domains in R-spondin 4) are likely to strongly perturb proper
function of the encoded protein (Krawczak and Cooper,
1996). Premature termination codons may preferably result in
nonsense-mediated mRNA decay, following detection of
faulty open reading frames and subsequent elimination of
‘‘imperfect messages’’ by a conserved mammalian surveil-
lance mechanism (Hentze and Kulozik, 1999).
We performed extensive in silico analyses to further
endorse the pathogenicity of the six RSPO4 missense
mutations identified to date, in detail p.Arg64Cys,
p.Gln65Arg, p.Cys73Tyr, p.Cys95Phe, p.Cys107Arg,
and p.Cys118Tyr (Bergmann et al., 2006; Blaydon et al.,
2006; and this study). First, striking evidence for the
pathogenicity of these aforementioned changes is proposed
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Figure 2. Pedigree of the Turkish consanguineous family with a total of nine affected individuals. Bottom left: hands and feet of affected individual V-1 showing
isolated total congenital anonychia with absence of finger- and toenails. Bottom right: electropherogram depicting the novel, non-conservative homozygous
missense mutation c.190C4T that leads to an amino-acid exchange from arginine to cysteine at position 64 (p.Arg64Cys) in exon 2 of the RSPO4 gene.
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by the evolutionarily highly conserved character of affected
amino acids, as demonstrated by multiple protein sequence
alignment that was generated with the program ClustalW
(http://ebi.ac.uk/clustalw/) using translation from genome
assemblies and expressed sequences (Figure 3, bottom left).
This program was also used to study the conservation of these
mutated RSPO4 amino acids among the four known human
R-spondin proteins (Figure 3, bottom right). PolyPhen is a
bioinformatics tool that predicts a possible impact of an
amino-acid substitution on the structure and function of a
human protein based on straightforward physical and
comparative considerations (http://genetics.bwh.harvard.
edu/pph/ or http://coot.embl.de/PolyPhen/). The results of
PolyPhen analysis strongly suggested that all tested missense
mutations would probably result in a dysfunctional protein
with position specific independent count score differ-
ences42, respectively. Utilization of the ConSeq prediction
software (http://conseq.bioinfo.tau.ac.il) corroborated these
findings. The conservation score (1¼ variable, 9¼ conserved)
of affected R-spondin 4 residues was 8 for the substitutions
p.Arg64Cys and p.Gln65Arg, and 9 for the mutations
p.Cys73Tyr, p.Cys95Phe, p.Cys107Arg, and p.Cys118Tyr,
respectively. Structurally, highly conserved residues 64, 65,
and 73 were evaluated as exposed, whereas the highly
conserved residues 95, 107, and 118 were predicted to be
buried. At last, we checked the SIFT version 2 bioinformatics
software (http://blocks.fhcrc.org/sift/SIFT_seq_submit2.html)
that also predicted convincing data with strong SeqRep
fractions and intolerable amino-acid changes with regard to
RSPO4 protein structure and function.
Conclusively, we have demonstrated that RSPO4 is
the major gene in autosomal-recessive anonychia and
that mutations mainly affect the highly conserved exons
2 and 3 encoding the furin-like cysteine-rich domains of
R-spondin 4.
MATERIALS AND METHODS
Patients
Detailed clinical data of the Kazakh family described in this study
have been published previously (Rigopoulos et al., 2006), whereas
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Figure 3. Simplified scheme (not drawn to scale) of the RSPO4 gene that spans approximately 44 kb of genomic DNA and comprises five exons that encode a
secreted protein of 234 amino acids. (Exons are depicted as bars: coding sequence¼ blackened bar, non-coding exonic sequence¼white bar; introns are
displayed by lines). RSPO4 mutations detected in this study (underlined) and those described in the literature are shown (blue¼ splice mutations,
red¼ truncating mutations, green¼missense mutations). Bottom left and right: in silico characterization of known RSPO4 missense mutations (the affected
arginine residue (p.R64) in the Turkish family is indicated). Multiple protein sequence alignment, generated with ClustalW, of the furin-like cysteine-rich
domains encoded by exons 2 and 3. Residues affected by RSPO4 missense mutations are shown on a gray background. Sequence comparison shows that the
identified RSPO4 missense mutations affect amino acids that are highly conserved through evolution (bottom left) and among members of the R-spondin protein
family (bottom right). Abbreviations and protein annotations used: Hs, Homo sapiens NP_001025042; Mm, Mus musculus BC116367.1; Rn, Rattus norvegicus
ENSRNOP00000052312; Cf, Canis familiaris ENSCAFP00000010193; Pt, Pan troglodytes ENSPTRP00000022516; Bt, Bos taurus ENSBTAP00000039099; Ma,
Macaca mulatta ENSMMUP00000037654; Md, Monodelphis domestica ENSMODP00000024370; Xt, Xenopus tropicalis ENSXETP00000007765. R-spondin 4
NP_001025042, R 1 NP_001033722, R 2 NP_848660, and R 3 NP_116173.
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the clinical characteristics of the consanguineous Turkish pedigree
were recently presented at the 15th Congress of the European
Academy of Dermatology and Venereology (EADV) in Rhodes,
Greece (Koc et al., 2006). All molecular data are described for the
first time in this study.
Briefly, all affected individuals had isolated total congenital
anonychia (Figures 1 and 2). In both families, the parents were
unaffected. Further, family and medical histories were unremark-
able, respectively. Patients were of normal height and proportionate
stature and not different in any aspect except for anonychia from
their healthy siblings. X-rays of the upper and lower limbs did not
show any abnormality. No additional malformations were found on
clinical examination, neither of ectodermal structures nor of sensory
or inner organs. All subjects were of normal intelligence. We
obtained blood samples from all patients and their parents and
extracted genomic DNA using standard procedures. Signed and
informed consent was obtained from patients and family members
using protocols approved by the Institutional Ethics Review Board at
the University of Aachen and collaborating institutions. Experiments
were carried out with institutional approval and in adherence to the
Declaration of Helsinki Principles. As the father of the Kazakh family
was not available for analysis, paternal haplotypes in this kindred
were deduced from the haplotypes of his children.
Haplotype analysis
In both multiplex families, we initially performed linkage analysis
with microsatellite markers located in the RSPO4 region on
chromosome 20p13 (see Figure 1 for exemplification of the Kazakh
family). Primers for PCR amplification were as published in the
Genome Database (http://www.gdb.org) and are available on
request. Microsatellite markers were analyzed on an ABI PRISM
3130 genetic analyzer (Applied Biosystems, Darmstadt, Germany)
with a universal fluoresceinated primer ComF (50-TACGCATCC
CAGTTTGAGACG-30) as follows (Warner et al., 1996). Each
microsatellite marker was amplified in a three primer PCR reaction
in which the forward primer of the two specific primers was tailed
with the sequence corresponding to the universal fluorescent primer
ComF (specFcom). A 10:1 molar ratio of primers ComF to specFcom
was used to ensure that primer specFcom is exhausted during the
early amplification cycles.
Mutation analysis
We performed direct sequencing of the entire coding region
including exon–intron boundaries and the proximal adjacent 50
untranslated region (1 kb upstream of the ATG initiation codon) of
the RSPO4 gene (GenBank: NM_001029871; mutation numbering
þ 1 corresponds to the A of the ATG translation initiation codon).
Genomic DNA from affected individuals was amplified by PCR with
oligonucleotide primers complementary to flanking intronic
sequences. Primers were designed using the Primer3 program
(http://www-genome.wi.mit.edu/cgi-bin/primer/primer3.cgi) (primer
sequences and PCR conditions are available on request). PCR
products were purified with the DNA Clean & ConcentratorTM-5 kit
(Zymo Research, Orange, CA) and sequenced employing ABI
BigDye chemistry (Applied Biosystems). The same primers as for
PCR were used as sequencing primers. Samples were run and
analyzed on an ABI PRISM 3130 genetic analyzer (Applied
Biosystems). Once a mutation had been identified, segregation of
the altered allele was tested by direct sequencing of parental probes.
The missense mutation detected in this study was not present in 200
ethnically matched Turkish control chromosomes tested by BtsCI
restriction enzyme analysis (New England Biolabs, Beverly, MA).
Web resources
The human genome databases are available at http://genome.ucsc.
edu/ and http://www.ncbi.nlm.nih.gov/. Primer 3 is available
at http://www.broad.mit.edu/cgi-bin/primer/primer3_www.cgi/. The
Online Mendelian Inheritance in Man (OMIM) database is available
at http://www.ncbi.nlm.nih.gov/omim. The GenBank database is
available at http://www.ncbi.nlm.nih.gov/Genbank/. ClustalW align-
ment is available at http://www.ebi.ac.uk/clustalw/. Databases for
in silico analysis of amino-acid substitutions are available at http://
genetics.bwh.harvard.edu/pph/ or http://coot.embl.de/PolyPhen/
(PolyPhen prediction tool), http://conseq.bioinfo.tau.ac.il (ConSeq
software), and http://blocks.fhcrc.org/sift/SIFT_seq_submit2.html
(SIFT version 2).
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